Back to mobile site
Get it on Google Play

Clene submits NDA to FDA for ALS drug CNM-Au8

October 19, 2026 8:00 AM EDT Send to a Friend
Clene Inc. (Nasdaq: CLNN) announced it submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration earlier ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login